Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 62
Filtrar
Mais filtros

Base de dados
País de afiliação
Intervalo de ano de publicação
3.
Rev. chil. infectol ; 19(supl. 2): S140-S148, 2002. tab, graf
Artigo em Espanhol | LILACS | ID: lil-314946

RESUMO

En el transcurso de los años hemos sido testigos de un creciente problema de resistencia antimicrobiana, fenómeno que involucra cada día mayor número de cepas, nuevas especies y nuevos mecanismos. En noviembre de 1997 iniciamos una red de vigilancia de resistencia antimicrobiana PRONARES (Programa Nacional de Resistencia), en diferentes hospitales del país, que trabajando un protocolo común (20 cepas por síndrome clínico por mes) y utilizando un programa computacional WHONET (diseñado para vigilancia), nos permitiera detectar y monitorear el problema de la resistencia bacteriana en Chile. Los resultados del primer semestre de este año reportan 5.251 cepas de diferentes síndromes clínicos. En ITU, Escherichia coli (1.088 cepas) demostró alta susceptibilidad a todos los antimicrobianos, Klebsiella (1.000 cepas) demostró un perfil de resistencia más elevado, en cepas de Enterococcus spp se observó 30 por ciento de resistencia a ciprofloxacina y 2 por ciento a nitrofurantoína. Entre 899 cepas procedentes de infecciones invasoras, Staphylococcus aureus (555 cepas), mostró elevado perfil de resistencia a cloxacilina 40 por ciento superior -40 por ciento (21 por ciento) al observado en cepas aisladas de piel y tejido blandos (550). Shigella spp, (137 cepas) presentó 80 por ciento de resistencia ampicilina y 32 por ciento a cloranfenicol; ciprofloxacina y furazolidona demostraron muy buena actividad in vitro frente a este enteropatógeno. Al comparar cepas nosocomiales y de la comunidad, las primeras mostraron un perfil de mayor resistencia. Mantener una red nacional de vigilancia de resistencia se hace cada vez más necesario para orientar el uso adecuado de antibacterianos y evitar así que el fenómeno aumente


Assuntos
Humanos , Resistência Microbiana a Medicamentos , Vigilância de Produtos Comercializados
4.
Rev. méd. Chile ; 127(12): 1447-52, dic. 1999. tab
Artigo em Espanhol | LILACS | ID: lil-258068

RESUMO

Background: Diseases produced by Streptoccocus pyogenes are still a problem in Chile, as in the rest of the world. It exhibits in vitro susceptibility to different antimicrobials, but penicillin continues to be the treatment of choice. Alternative drugs have been developed for allergic patients, such as erythromycin, new macrolides and cephalosporins. Nevertheless, resistant strains are appearing due to the indiscriminate use of macrolides. Aim: To assess present antimicrobial susceptibility of S Pyogenes strains isolated from chilean patients. Material and Methods: The susceptibility to penicillin, macrolides, clindamycin, cephalotin and vancomycin of 153 S Pyogenes strains, obtained from different health centers of the Metropolitan Region and isolated between 1996 and 1998, was assessed using the Kirby-Bauer method. Agar dilution minimal inhibitory concentration was then determined to macrolide resistant strains. Results: All strains were susceptible to penicillin. There was a 7.2 percent cross-resistance to macrolides. Conclusions: These results confirm that S Pyogenes resistance to macrolides has increased considerably in the Metropolitan Region of Chile during the last years


Assuntos
Streptococcus pyogenes/efeitos dos fármacos , Antibacterianos/farmacocinética , Técnicas In Vitro , Penicilinas/farmacocinética , Resistência Microbiana a Medicamentos , Clindamicina/farmacocinética , Vancomicina/farmacocinética , Testes de Sensibilidade Microbiana , Cefalosporinas/farmacocinética , Eritromicina/farmacocinética , Roxitromicina/farmacocinética
5.
Rev. méd. Chile ; 128(12): 1319-26, dic. 2000. tab
Artigo em Espanhol | LILACS | ID: lil-281990

RESUMO

Background: Respiratory pathogens are becoming increasingly resistant to antimicrobials. A new group of drugs, called respiratory quinolones have been synthesized to overcome this problem. Aim: To study the in vitro susceptibility of respiratory pathogens to old and new antimicrobials. Material and methods: Forty five strains of S pneumoniae, 44 strains of H influenzae, 21 strains of M catarrhalis, 10 strains of methicillin susceptible S aureus and 20 strains of methicillin resistant S aureus were studied. All were isolated from community acquired respiratory infections during 1999. Minimal inhibitory concentrations of moxifloxacin, amoxicilin, amoxicilin/clavulanic acid, clarithromycin, azithromycin, ciprofloxacin and levofloxacin were determined using the Etest method. Betalactamase production by H influenzae and M catarrhalis was also studied. Results: S pneumoniae strains were 100 percent susceptible to quinolones and cotrimoxazole, 2 percent were resistant to macrolides, 11 percent were resistant to amoxicilin/clavulanic acid and 47 percent were resistant to cefuroxime. H influenzae was 100 percent susceptible to quinolones, azithromycin and amoxicilin/clavulanic acid. There was a 53 percent resistance to cotrimoxazole, 21 percent to amoxicilin, 9 percent to clarithromycin and 7 percent to cefuroxime. M catarrhalis was 100 percent susceptible to quinolones and 100 percent resistant to amoxicilin, 5 percent resistant to macrolides, 14 percent resistant to amoxicilin/clavulanic acid, 20 percent to cefuroxime and 30 percent to cotrimoxazole. Methicilline susceptible S aureus was susceptible to all antimicrobials and methicillin resistant S aureus was resistant to all. Conclusions: Moxifloxacin and the new respiratory quinolones can be useful in the treatment of respiratory infections


Assuntos
Infecções Respiratórias/tratamento farmacológico , Anti-Infecciosos/farmacologia , Antibacterianos/farmacologia , Técnicas In Vitro , Staphylococcus aureus/efeitos dos fármacos , Streptococcus pneumoniae/efeitos dos fármacos , Resistência Microbiana a Medicamentos , Haemophilus influenzae/efeitos dos fármacos , Moraxella catarrhalis/efeitos dos fármacos , Antibacterianos/farmacologia
6.
Rev. méd. Chile ; 128(7): 758-65, jul. 2000. tab
Artigo em Espanhol | LILACS | ID: lil-270886

RESUMO

Backgrund: Chlamydia trachomatis is one of the most common identifiable infectious agents in neonatal conjunctivitis. It also causes pneumonitis, that is preceded by conjunctivitis in one third of cases. Aim: To asses the prevalence of Chlamydia trachomatis in newborns with conjunctivitis. Patients and methods: In 162 newborns, coming from 14 Primary Health Centers from Santiago de Chile, C. trachomatis was detected by indirect fluorescence and two polymerase chain reaction (PCR 1 and 2), wich amplified different sequences from the common endogenous plasmid. Those patients with positive indirect fluorescence and PCR 2 were definedas infected: Results: The prevalence of C. trachomatis was 8 percent, and the distribution of the positive cases was similar in the different Health Centers. Other isolates were: S. aureus (9.8 percent), S. pneumoniae (8 percent), S. viridans (6.2 percent) y H. influenzae (5.5 percent). Conclusions: The prevalence of C. trachomatis in neonatal conjunctivitis in Chile is similar to that of developed countries. Therefore, C. trachomatis should be considered in the election of antimicrobials for the treatment of neonatal conjunctivitis, to avoid ocular and respiratory complications


Assuntos
Humanos , Recém-Nascido , Masculino , Feminino , Chlamydia trachomatis/isolamento & purificação , Conjuntivite de Inclusão/etiologia , Doenças do Recém-Nascido/etiologia , Chlamydia trachomatis/efeitos dos fármacos , Chlamydia trachomatis/patogenicidade , Reação em Cadeia da Polimerase , Fatores de Risco , Antibacterianos/uso terapêutico , Conjuntivite de Inclusão/diagnóstico , Conjuntivite de Inclusão/tratamento farmacológico , Doenças do Recém-Nascido/diagnóstico , Fatores Socioeconômicos , Técnica Direta de Fluorescência para Anticorpo
7.
Rev. chil. infectol ; 17(2): 122-8, 2000. tab
Artigo em Espanhol | LILACS | ID: lil-269403

RESUMO

Se analiza un brote de gastroenteritis por shigella sonnei, ocurrido en una escuela básica de una comuna de Santiago, en marzo de 1997. En esta escuela, con una matricula de 1470 niños entre 5 y 14 años de edad, 350 se beneficiaban con el programa de alimentación escolar (pae) y almorzaban en el establecimiento. Treinta y cinco de los 350 niños del pae presentaron simultáneamente gastroenteritis que motivó consulta en un servicio de emergencia, 2 de los cuales presentaron diarrea con sangre requiriendo hospitalización. Durante los cinco días posteriores se registraron 189 nuevos casos en la escuela. Frente a la notificación, se efectuó visita epidemiológica a la escuela, obteniéndose muestras de deposición para estudio de bacterias y virus enteropatógenos en 65 niños sintomáticos y en los tres manipuladores de alimentos. Se identificó s. sonnei en 20,5 porciento de los coprocultivos y todas las cepas tenían el mismo antibiotipo. La búsqueda de virus entéricos (rotavirus, calcivirus) dio resultados negativos. En los manipuladores de alimentos no se detectó enteropatógenos bacterianos ni virales. La presentación del brote plantea una toxiinfección por s. sonnei, iniciada probablemente por ingestión de alimentos (tasa de ataque primario 10 porciento) y luego transmisión persona a persona (tasa de ataque secundario 16,9 porciento) Para controlar el brote se reforzaron medidas de higiene personal y de saneamiento ambiental a través de educación a toda la comunidad escolar y el control sanitario del establecimiento. A partir del quinto día de iniciado el primer caso, se administró cotrimoxazol, durante cinco días, sólo a los casos sintomáticos. El brote se controló al noveno día


Assuntos
Humanos , Pré-Escolar , Criança , Masculino , Feminino , Adolescente , Disenteria Bacilar/epidemiologia , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico , Contaminação de Alimentos/análise , Surtos de Doenças/estatística & dados numéricos , Disenteria Bacilar/tratamento farmacológico , Medidas em Epidemiologia , Instituições Acadêmicas/estatística & dados numéricos , Shigella/patogenicidade
8.
Rev. chil. pediatr ; 67(5): 195-9, sept.-oct. 1996. graf
Artigo em Espanhol | LILACS | ID: lil-197820

RESUMO

Las infecciones neumocócicas causan enfermedades graves en los niños. Se han observado cambios epidemiológicos en las infecciones por Streptococcus pneumoniae, como aumento de la incidencia, desarrollo creciente de resistencia antimicrobiana y brotes infecciosos epidérmicos.El estudio de portadores es útil para vigilar la aparición y desarrollo de la resistencia antimicrobiana y de los serotipos prevalentes. Con el propósito de determinar la prevalencia de cepas resistentes de S. pneumoniae en niños que asisten a jardines infantiles de Santiago y los serotipos más frecuentes en la nasofaringe, se efectuó cultivo de hisopado faríngeo y nasal obtenido entre noviembre de 1994 y agosto de 1995 de 200 de ellos, cuya edad era entre 3 meses y 4 años (97 < de 2 años y 103 > de 2 años). Las muestras fueron sembradas en agar sangre con 5 por ciento de sangre de cordero, con o sin gentamicina (5 µg/ml) e incubadas en ambiente con dióxido de carbono. La resistencia antimicrobiana se evaluó mediante disco de oxacilina,microdilución en caldo y E-test.En 60,2 por ciento de los casos se aisló S. pneumoniae de la nasofaringe; 28,4 por ciento de las cepas eran resistentes a penicilina (20,3 por ciento con resistencia moderada y 2,1 por ciento elevada), 2 por ciento eran resistentes a cloranfenicol. No se encontraron cepas resistentes a eritromicina, cefotaxima o vancomicina. La frecuencia de cepas resistentes a la penicilina fue similar en los niños menores y mayores de 2 años. E serotipo más frecuente fue el 6A


Assuntos
Humanos , Masculino , Feminino , Lactente , Pré-Escolar , Doenças Nasofaríngeas/microbiologia , Infecções Pneumocócicas/epidemiologia , Streptococcus pneumoniae/isolamento & purificação , Creches , Resistência Microbiana a Medicamentos , Testes de Sensibilidade Microbiana , Resistência às Penicilinas , Streptococcus pneumoniae/efeitos dos fármacos
9.
Rev. chil. pediatr ; 65(1): 1-6, ene.-feb. 1994. tab
Artigo em Espanhol | LILACS | ID: lil-140460

RESUMO

El perfil plasmidial es utilizado frecuentemente en estudios epidemiológicos para distinguir cepas con características fenotípicas similares. Para evaluar la utilidad de esta técnica en la tipificación de klebsiella pneumoniae, estudiamos dos brotes de infección intrahospitalaria ocurridos en la unidad de neonatología del Hospital Carlos Van Buren. Se analizó el perfil plasmidial de 12 cepas aisladas de un brote producido en 1990, 5 cepas aisladas de un brote ocurrido en 1992 y 31 cepas aisladas durante 1992 en otros servicios del hospital y no relacionadas con brotes. Como patrón fenotípico se utilizó el perfil de resistencia a los antimicrobianos (antibiótipo). Del primer brote 11/12 cepas presentaron el mismo perfil plasmidial y 5/5 cepas del segundo brote, siendo ambos perfiles distintos entre sí. Los patrones plasmidiales de las cepas endémicas de otros servicios fueron variables y diferentes de las cepas epidémicas. En ambos brotes, el antibiótipo de las cepas epidémicas fue concordante con el patrón plasmidial, excepto en una cepa del primer brote. Estos resultados sugieren que el análisis del perfil plasmidial es una técnica adecuada para discriminar cepas epidémicas y endémicas de K. pneumoniae y por lo tanto puede ser útil en estudios de brotes por este agente


Assuntos
Recém-Nascido , Técnicas de Tipagem Bacteriana/estatística & dados numéricos , Resistência Microbiana a Medicamentos/genética , Klebsiella pneumoniae/genética , Surtos de Doenças , Infecção Hospitalar/microbiologia , Klebsiella pneumoniae/isolamento & purificação
10.
Rev. méd. Chile ; 129(7): 719-726, jul. 2001. tab, graf
Artigo em Espanhol | LILACS | ID: lil-300036

RESUMO

Background: Acute bacterial meningitis still has a high mortality and rate of complications. Aim: To assess the impact of anti H influenzae vaccination on the epidemiology of acute bacterial meningitis in Chilean children. Material and methods: A retrospective study of hospital discharge records of patients with acute bacterial meningitis. Causative agents were studied globally, by hospital and by age group. The changes in etiology from 1989 to 1995 were also assessed. Between 1996 and 1998, only those patients with acute bacterial meningitis caused by H influenzae were recollected. Results: In the period prior to vaccination (1989-1995), 1000 cases were registered. The main causative agents were N meningitidis in 33.8 percent, H influenzas type b in 21.9 percent and S pneumoniae in 15.4 percent. The incidence of H influenzae decreased in the period from 36.4 to 9.9 percent (p<0.001) and the incidence of N meningitidis increased from 22.9 to 52.1 percent (p <0.001). The incidence of S pneumoniae did not change significantly. H influenzae predominated in children between 4 and 24 months of age and N meningitidis predominated in children over 25 months of age. In the period after the introduction of vaccination (1995-1998), there was a further decrease in the incidence of H influenzae from 10 to 2 percent (p <0.001). Until 1997, there was a considerable increase in the incidence of N meningitidis, specially in children over 25 months of age. It declined in 1998 to 38 percent. Conclusions: There was a reduction in the incidence of acute bacterial meningitis caused by H influenzae prior to the introduction of the vaccine against H influenzae type b. The decrease was more pronounced after the introduction of the vaccine


Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Pré-Escolar , Adolescente , Adulto , Haemophilus influenzae , Meningites Bacterianas , Vacinas Anti-Haemophilus , Chile , Haemophilus influenzae , Incidência , Meningites Bacterianas , Meningite por Haemophilus , Programas de Imunização , Epidemiologia Descritiva , Meningite Meningocócica/epidemiologia , Meningite Meningocócica/etiologia , Meningite Meningocócica/prevenção & controle , Meningite Pneumocócica/epidemiologia , Meningite Pneumocócica/etiologia , Meningite Pneumocócica/prevenção & controle
11.
Rev. méd. Chile ; 130(3): 275-280, mar. 2002. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-314853

RESUMO

Background: Chloramphenicol is one of the therapeutic options for shigellosis, but resistance to this antimicrobial is increasing. Aim: To characterize molecular mechanisms conferring resistance to chloramphenicol (CmR) in Shigella flexneri strains isolated from Chilean children with acute diarrhea. Material and methods: Thirty one Shigella filexneri strains, including 22 with the CmR phenotype were analyzed. Strains were tested for antimicrobial susceptibility by plate dilution and for the presence of an internal fragment of the cat gene encoding for chloramphenicol o-acetyl-transferase, by polymerase chain reaction and Southern blot analysis. Results: All CmR strains had a minimal inhibitory concentration over 64 µg/ml and amplified the internal fragment of the cat gene. Southern blot analyses indicated that this gene was located in the bacterial chromosome. Conclusions: Resistance to chloramphenicol in this group of Shigella flexneri strains was mediated by a chromosomally located cat gene


Assuntos
Humanos , Criança , Shigella flexneri , Resistência ao Cloranfenicol , Diarreia , Shigella flexneri , Cloranfenicol O-Acetiltransferase , Testes de Sensibilidade Microbiana , Reação em Cadeia da Polimerase , Diarreia
12.
Rev. méd. Chile ; 130(6): 603-609, jun. 2002. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-317490

RESUMO

Background: Enterohemorrhagic Escherichia coli (EHEC), is an emergent pathogen that causes sporadic infections and outbreaks of gastroenteritis associated with consumption of contaminated food products. Because detection of EHEC in diarrhea patients is not routinely performed, infection is most probably underestimated. Aim: To compare three techniques to detect EHEC: Colony hybridization with DNA probes, polymerase chain reaction (PCR) for the detection of stx1 and stx2 genes and immunoenzymatic detection by ELISA (Premier EHEC) of Stx1 and Stx2 toxins. Material and methods: Four outbreaks of food-borne gastroenteritis were studied including 16 patients and 78 strains of E coli. Twenty one (26,9 percent) strains, hybridized with the stx1 probe, 1 (1,3 percent) hybridized only with the stx2 probe and 36 (46,1 percent) with both probes. PCR amplification for cytotoxin genes was observed in 6 strains (7,7 percent) from the second outbreak studied. The immunoenzimatic assay detected the cytotoxins in 18 (23,0 percent), of the 78 studied strains. Agreement between probes and ELISA was 44,8 percent, between PCR and probes 34,7 percent and 82,4 percent between ELISA and PCR. Conclusions: These results indicate a variable yield among different EHEC detection techniques. Considering PCR as the gold standard, ELISA technique showed a better sensitivity and specificity than probes


Assuntos
Humanos , Escherichia coli , Infecções por Escherichia coli , Gastroenterite , Ensaio de Imunoadsorção Enzimática , Sondas de DNA , Reação em Cadeia da Polimerase , Citotoxinas , Escherichia coli , Infecções por Escherichia coli , Gastroenterite , Análise de Sequência com Séries de Oligonucleotídeos
13.
Rev. méd. Chile ; 128(12): 1335-41, dic. 2000. tab
Artigo em Espanhol | LILACS | ID: lil-281992

RESUMO

Background: There is a high prevalence of infection by Enterohemorrhagic Escherichia coli (EHEC) and patients with hemolytic uremic syndrome (HUS) in Argentina. Aim: To study cattle and pigs as a possible reservoir of EHEC in Argentina. Material and methods: One hundred two healthy animals (68 cattles and 31 pigs) from a livestock in Argentina, were studied. Stool samples were obtained with a rectal swab. The strains were identified by DNA hybridization with specific gene probes detecting Shiga-like toxin 1 and 2 (Stx1, Stx2), and hly gen related to fimbrial adhesin-associated plasmid. EHEC strains were serogrouped using comercial antisera. Results: EHEC was isolated from 30 out of 68 bovines cultures (44.1 percent) and from 25 out of 31 pigs (58.1 percent). Isolates carrying genes codifying both Stx1 and Sxt2, were observed in 50 percent of cattle and 63.9 percent of pigs. The gene which codifies for hemolysin (associated to fimbrial adhesin) was observed in about 41 percent of EHEC isolates. Strains belonging to serogroups O26, O111, and O157 were isolated from cattle, and O111, and O157 from pigs. Conclusions: The high percentage of EHEC in both cattle and pigs and the presence of human infection-associated serogroups, suggests that these animals are a reservoir of EHEC associated with disease in humans


Assuntos
Animais , Bovinos , Escherichia coli/isolamento & purificação , Infecções por Escherichia coli/epidemiologia , Argentina/epidemiologia , Suínos/microbiologia , Reservatórios de Doenças/estatística & dados numéricos , Bovinos/microbiologia , Estudos Transversais , Escherichia coli/genética , Genótipo
14.
Rev. méd. Chile ; 130(5): 495-501, mayo 2002. tab, graf
Artigo em Espanhol | LILACS | ID: lil-317369

RESUMO

Background: Foodborne diseases are becoming an important cause of morbidity in Chile. In the Metropolitan Region of Chile, the Environmental Health Service started a surveillance program for foodborne diseases in 1994. In 2000, this program was complemented with an etiologic study of individuals involved in outbreaks. Aim: To report the incidence of foodborne outbreaks in the Metropolitan Region of Chile and its causative agents. Results: One hundred ninety outbreaks of foodborne diseases were reported in 1999 and 260 in 2000. The Southern Metropolitan health service had the higher incidence rates (7.5 in 1999 and 8.2 in 2000). The mean attack rates were 25 percent in both periods, affecting 1248 individuals in 1999 and 1774 in 2000. In 18 percent of outbreaks, a pathogen was identified; the most frequent agents were Salmonella Spp, Staphylococcus aureus and Shigella. In 15 percent of subjects, the cause was histamine or chemical agents. In the rest of the cases, the cause was not identified. The foods with higher risk of causing foodborne diseases were hot prepared dishes, home made goat cheese and meats. Conclusions: The incidence rates of foodborne disease in Metropolitan Area of Chile are high and maybe underestimate, only in a low rate of outbreaks was possible to have samples for etiologic studies. For a better understanding of this problem, timely notification of foodborne diseases must be encouraged and educational campaigns about the proper manipulation of food items must be implemented


Assuntos
Humanos , Contaminação de Alimentos/estatística & dados numéricos , Doenças Transmitidas por Alimentos/epidemiologia , Salmonella , Shigella , Staphylococcus , Surtos de Doenças , Manipulação de Alimentos
15.
Rev. méd. Chile ; 129(8): 877-885, ago. 2001. tab, graf
Artigo em Espanhol | LILACS | ID: lil-300148

RESUMO

Background: PRONARES (Programa Nacional de Vigilancia de Resistencia) is a national surveillance program for antimicrobial susceptibility, focused in different syndromes and among these, urinary tract infections. The work is done in a laboratory net that uses common protocols and whose data are centrally analyzed using the WHONET program. Aim: To analyze the pattern of antimicrobial susceptibility of agents causing urinary infections in children in the period 1997-1999. Material and methods: In the study period, 5,525 strains were analyzed. Of these, 2,307 came from pediatric patients (1,495 hospitalized and 803 ambulatory). Results: The most common causative agent was E. coli in 74,2 percent of cases, followed by Klebsiella spp in 8,2 percent and other agents in a lower frequency. Of E. coli strains, 74 percent were resistant to ampicillin, 52 percent to clotrimoxazole and 30 percent to first generation cephalosporins. These strains were sensitive to second and third generation cephalosporins, aminoglycosides, ciprofloxacin and nitrofurantoin. Strains from nosocomial or community infections had similar antimicrobial susceptibility. Klebsiella spp had a high rate of antimicrobial resistance (over 40 percent), that was even higher among nosocomial strains. It was 90 percent susceptible to ciprofloxacin and 100 percent to imipenem. All centers from which strains came had a similar pattern of susceptibility, with the exception of a pediatric center that had significantly higher resistance levels. Conclusions: The current therapeutic recommendations for urinary tract infections in children caused by E coli, are still pertinent, but the use of first generation cephalosporins must be cautious. The treatment of Klebsiella spp requires an individual antibiogram


Assuntos
Humanos , Masculino , Feminino , Infecções Urinárias , Resistência Microbiana a Medicamentos , Anti-Infecciosos Urinários , Pacientes Ambulatoriais , Proteus mirabilis , Infecções Urinárias , Chile , Estudos Longitudinais , Controle de Infecções , Escherichia coli , Klebsiella pneumoniae , Infecção Hospitalar/etiologia , Infecção Hospitalar/tratamento farmacológico
16.
Rev. méd. Chile ; 127(9): 1033-40, sept. 1999. tab, graf
Artigo em Espanhol | LILACS | ID: lil-255277

RESUMO

Background: the computer program WHONET generates a common database to analyze local or general antimicrobial resistance of bacteria. A surveillance of agents causing urinary tract infections in Chile has been performed using this program. Aim: to report the results after 12 months of urinary tract infection agent surveillance. Material and methods: since november, 1997, a surveillance of in vitro antimicrobial resistance, using agar diffusion techniques, has been performed in 20 to 40 bacterial strains per month, isolated from 11 hospitals in the country. Results have been analyzed using WHONET program. Results: in first 12 months, 3144 strains, 1625 coming from outpatients, have been studied. Seventy four percent of isolated strains were E. coli, 19 percent were other enterobacteria, 4.1 percent were non fermenting bacilli and 2.1 percent were Gram (+) cocci. Sixty five percent of E coli strains were resistant to ampicillin, 11 percent to cefazolin, 2.5 percent to cefuroxime, 19 percent to ceftriaxone, 9 percent to ceftazidime, 4.2 percent to gentamicin 1.3 percent to amikacin, 5.6 percent to ciprofloxacin, 8.4 percent to grepafloxacin, 4.3 percent to nitrofurantoin and 43 percent to trimeproprim/sulphamethoxazole. Eighty two percent of other enterobacteria strains were resistant to ampicillin, 45.5 percent to cefazolin, 33.5 percent to cefuroxime, 26.6 percent to ceftriaxone, 21.5 percent to ceftazidime, 30.3 percent to gentamicin 17.2 percent to amikacin, 21 percent to ciprofloxacin, 16.3 percent to grepafloxacin, 48.2 percent to nitrofurantoin and 44.6 percent to trimeproprim/sulphamethoxazole. There were differences in betalactamic resistance among hospitals. Conclusions: noteworthy is the high resistance rates to third generation cephalosporins, evidenced when the new cutoff values for E coli and klebsiella spp are used. This national surveillance provides updated information on antimicrobial resistance of agents causing urinary tract infections


Assuntos
Humanos , Masculino , Feminino , Adolescente , Pré-Escolar , Lactente , Adulto , Pessoa de Meia-Idade , Infecções Urinárias/tratamento farmacológico , Resistência Microbiana a Medicamentos , Infecções Urinárias/etiologia , Ceftriaxona/farmacologia , Resistência a Ampicilina , Fatores Etários , Enterobacteriaceae/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Ampicilina/farmacologia , Hospitais Públicos
18.
Rev. méd. Chile ; 124(1): 7-10, ene. 1996.
Artigo em Espanhol | LILACS | ID: lil-173298

RESUMO

Are the emergent pathogenic microbes, persistent bacteria that have changed their virulence or new diagnostic techniques now allow their recognition? Or, have they found a new possibility of transmission due to ecological, social or cultural changes?. The present editorial analyses the geographical distribution, features and host factors that favor infections by Helicobacter pylori, entretohemorhagic E. coli, invasive Streptococcus pyogenes and Borrelia Burgdorfi. The surveillance and care of infections caused by emergent germs requires laboratory learning programs as those established in United States


Assuntos
Humanos , Bactérias/patogenicidade , Infecções Bacterianas/epidemiologia , Doenças Transmissíveis/epidemiologia , Streptococcus pyogenes/patogenicidade , Helicobacter pylori/patogenicidade , Borrelia burgdorferi/patogenicidade , Escherichia coli/patogenicidade
19.
Rev. chil. infectol ; 11(4): 210-5, 1994. tab
Artigo em Espanhol | LILACS | ID: lil-207327

RESUMO

Las infecciones respiratorias bacterianas representan causa frecuente de consulta a nivel ambulatorio. Para su tratamiento existen diferentes alternativas de antimicrobianos, que se deben usar por períodos de 10 a 14 días. Dentro de los nuevos antimicrobianos, azitromicina, un azálido relacionado estructuralmente con la eritromicina, tiene características interesantes por su amplio espectro de acción que cubre los patógenos respiratorios y la elevada concentración en tejidos respiratorios inflamados, que se mantiene por perídos prolongados, lo que permite dosificarla una vez al día y administrarla por tiempos cortos, sólo 3 dias. En un estudio multicéntrico abierto se evaluó la eficacia y tolerancia de azitromicina en el tratamiento de infecciones respiratorias, con la participación de médicos de diferentes ciudades. Ingresaron al estudio 722 pacientes y de ellos 718 fueron evaluables, el promedio de edad fue 41,4 años (rango 16-90), y 57,8 por ciento eran de sexo femenino. Los diagnósticos principales fueron: faringoamigdalitis (19,1 por ciento), sinusitis (20 por ciento), bronquitis aguda (47,3 por ciento) y neumonía (5 por ciento), Se indicó azitromicina 500 mg diarios durante 3 días y se controlaron entre el 5 al 7 día. Se observó éxito terapéutico (curación o mejoría), en 97,3 por ciento de los pacientes y fracasos en 2,7 por ciento. Efectos adversos se registraron en 2,9 por ciento de los pacientes (27/718), principalmente eipigastralgia, pirosis y diarrea, de intensidad leve en 11 y moderada en 10 casos. En conclusión, azitromicina resultó eficaz y bien tolerada en el tratamiento de infecciones respiratorias altas y bajas


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Azitromicina , Infecções Respiratórias/tratamento farmacológico , Assistência Ambulatorial
20.
Rev. chil. pediatr ; 66(4): 220-6, jul.-ago. 1995. tab
Artigo em Espanhol | LILACS | ID: lil-164972

RESUMO

Se describen cambios registrados en los agentes asociados a otitis media aguda y sinusitis en niños, subrayando el aumento relativo de H. influenzae no tipificables, la emergencia de Moraxella catarrhalis, agentes que, junto con S. pneumoniae, representan las 3 principales causas de otitis media aguda y sinusitis en niños. Paralelamente se analizan variaciones observadas en la sensibilidad a los antimicrobianos con que tradicionalmente se tratan estas afecciones, como ampicilina o cotrimoxazol. Se comenta la aparición de resistencia a penicilina en cepas de S. pneumoniae, dando un panorama de la situación nacional y del pérfil de resistencia a otros antimicrobianos. Se discute el manejo de la faringoamigdalitis estreptocócica, ya que, si bien no se han observado modificaciones en la sensibilidad del agente a la penicilina, como tampoco tolerancia a la penicilina en cepas chilenas, la eficacia clínica de penicilina para el tratamiento y erradicación del S. pyogenes está siendo revisada a la luz de algunos fenómenos microbiológicos que ocurren en la flora faríngea, como inactivación de la penicilina por las betalactamasas producidas por la flora comensal o interferencia con otras especies de Streptococcus


Assuntos
Humanos , Criança , Lactente , Pré-Escolar , Otite Média com Derrame/microbiologia , Faringite/microbiologia , Sinusite/microbiologia , Tonsilite/microbiologia , Haemophilus influenzae/efeitos dos fármacos , Haemophilus influenzae/patogenicidade , Moraxella catarrhalis/efeitos dos fármacos , Moraxella catarrhalis/patogenicidade , Faringe/microbiologia , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/patogenicidade , Streptococcus pyogenes/efeitos dos fármacos , Streptococcus pyogenes/patogenicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA